William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- STEM-Talk: Pascal Lee on returning to the Moon — and heading to Mars
- Aging Symposium draws experts to IHMC
- IHMC hosts Fredric G. Levin Lung Care Symposium March 27-28 in Pensacola
- Humanoid robotics and exoskeletons lead latest IHMC newsletter
- Celebrate Robotics Week at IHMC Open House on April 11, 2025
- Registration open for 2025 Summer Robotics Camp
- STEM-Talk: JP Errico on vagus-nerve stimulation, inflammation and chronic disease management
- STEM-Talk: Karl Herrup on shortcomings of Alzheimer’s research
- Pensacola attorney joins IHMC Board of Directors